The long noncoding RNA HORAS5 mediates castration‐resistant prostate cancer survival by activating the androgen receptor transcriptional program

Prostate cancer (PCa) is driven by the androgen receptor (AR)‐signaling axis. Hormonal therapy often mitigates PCa progression, but a notable number of cases progress to castration‐resistant PCa (CRPC). CRPC retains AR activity and is incurable. Long noncoding RNA (lncRNA) represent an uncharted reg...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Oncol
Main Authors: Parolia, Abhijit, Venalainen, Erik, Xue, Hui, Mather, Rebecca, Lin, Dong, Wu, Rebecca, Pucci, Perla, Rogalski, Jason, Evans, Joseph R., Feng, Felix, Collins, Colin C., Wang, Yuzhuo, Crea, Francesco
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2019
Assuntos:
Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6487714/
https://ncbi.nlm.nih.gov/pubmed/30776192
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/1878-0261.12471
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados